Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-17
2007-07-17
Wilson, James O. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S200000, C549S357000, C514S449000, C514S451000, C514S452000
Reexamination Certificate
active
10621276
ABSTRACT:
In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I):and pharmaceutically acceptable derivatives thereof, wherein R1, R2, R3, n, X and Y are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The present invention further provides compounds capable of inhibiting histone deacetylatase activity and methods for treating disorders regulated by histone deacetylase activity (e.g., cancer and protozoal infections) comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. The present invention additionally provides methods for modulating the glucose-sensitive subset of genes downstream of Ure2p. The present invention also provides methods for preparing compounds of the invention.
REFERENCES:
patent: 4639462 (1987-01-01), Krämer et al.
patent: 5059698 (1991-10-01), Schulthess et al.
patent: 5238781 (1993-08-01), Schädeli
patent: 5393741 (1995-02-01), Pettersen et al.
patent: 3242252 (1984-05-01), None
patent: 0 322 335 (1989-06-01), None
patent: 8-311321 (1996-11-01), None
patent: 9-124918 (1997-05-01), None
patent: WO 97/35990 (1997-10-01), None
patent: WO 98/16830 (1998-04-01), None
patent: WO98/16830 (1998-04-01), None
patent: WO 00/20415 (2000-04-01), None
patent: WO 00/35911 (2000-06-01), None
Sternson et al., “Synthesis of 7200 Small Molecules . . . ”, Organc Letters, vol. 3, No. 26, 2001, pp. 4239-4242.
Kuruvilla et al., “Dissecting glucose signalling with diversity . . . ”, Nature, vol. 416, 2002, pp. 653-657.
Sternson et al., “Split-Pool Synthesis of 1,3-Dioxanes . . . ”, J. Am. Chem. Soc. 001, 123, 1740-1747.
Aggarwal, et al., “Trifluoromethanesulfonic Acid, an Efficient Catalyst for the Hetero Diels-Alder Reaction and an Improved Synthesis of Mefrosol”,Tetrahecron Letters,38(14):2569-2572, 1997.
Antonjuk, et al., “Asymmetric Induction in the Additions of Anions of Allylic Sulfoxides to Benzaldehyde”,Aust. J. Chem.,33:2635-2651, 1980.
Blackwell, et al., “A One-Bead, One-Stock Solution Approach to Chemical Genetics: Part 1”,Chemistry&Biology,8:1167-1182, 2001.
Clemons, et al., “A One-Bead, One-Stock Solution Approach to Chemical Genetics: Part 2”,Chemistry&Biology,8:1183-1195, 2001.
Grozinger, et al., “Deacetylase Enzymes: Biological Functions and the Use of Small-Molecule Inhibitors”,Chemistry&Biology,9:3-16, 2002.
Haggarty, et al., “Domain-selective small-molecular inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation”,Proc. Natl. Acad. Sci,100(8):4389-4394, 2003.
Haggarty, et al; “Multidimensional Chemical Genetic Analysis of Diversity-Oriented Synthesis-Derived Deacetylase Inhibitors Using Cell-Based Assays”,Chemistry&Biology,10:383-396, 2003.
Hunter, et al., “An Enantioselective Synthesis of Benzylidene-Protected syn-3, 5-Dihydroxy Carboxylate Esters via Osmium, Palladium, and Base Catalysis”,Org Letter,3(7):1049-1052, 2001.
Imamoto, et al., “Preparation and Synthetic Use of Trimethylsilyl Polyphosphate. A New Stereoselective Aldol-Type Reaction in the Presence of Trimethylsily Polyphosphate”,J. Org. Chem.49:1105-1110, 1984.
Imamoto, et al., “The Reaction of Aryl Methyl Ketones with Aromatic Aldehydes in Trimethylsilyl Polyphosphate (PPSE), Formation of MESO-2,4,6-Trisubstituted-5-Acyl-1,3-Dioxe”,Tetrahedron Letters,23(14):1467-1470, 1982.
Johnstone, R. “Histone-Deacetylase Inhibitors: Novel Drugs for the Treatment of Cancer”,Nature,1:287-299, 2002.
Koeller, et al., “Chemical Genetic Modifier Screens: Small Molecule Trichostatin Suppressors as Probes of Intracelluler Histone and Tubulin Acetylation”,Chemistry&Biology,10:397-410, 2003.
Kuruvilla, et al., “Dissecting Glucose Signalling with Diversity-Oriented Synthesis and Small-Molecule Microarrays”,Nature,416:653-657, 2002.
Lin, et al., “Generation And Aldol Reaction of Enolate Anion Adjacent A η3-Allyl-Mo(CO)2Cp Moiety. A New Approach to the Stereoselective Synthesis of 1,3,5-Triol and 2-Vinyl-3 Hydroxyl-Tetrahydrofuran”,Tetrahedron Letters,31(52):7645-7648, 1990.
Lin, et al., “Role of the Histone Deacetylase Complex in Acute Promyelocytic Leukaemia”,Nature,391:811-814, 1998.
Magnaghi-Jaulin, et al., “Retinoblastoma Protein Represses Transcription by Recruiting a Histone Deacetylase”,Nature,391:601-604, 1998.
Marks, et al., “Histone Deacetylases and Cancer: Causes and Therapies”,Nature Reviews/Cancer,1:194-202, 2001.
Pyne, et al., “Reactions of Lithiated N-Tosyl S-Phenyl S-2- Propenyl Sulfoximine with Aldehydes”,Sulfur Letters,20(6):255-260, 1997.
Schreiber, et al., “Chemical Genetics Resulting from a Passion for Synthetic Organic Chemistry”,Bioorganic&Medicinal Chemistry,6:1127-1152, 1998.
Schreiber, et al., “Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery”,Science,287:1964-1969, 2000.
Sternson, et al., “Synthesis of 7200 Small Molecules Based on a Substructural Analysis of the Histone Deacetylase Inhibitors Trichostatin and Trapoxin”,Organic Letters,3(26):4239-4242, 2001.
Sternson, et al., “Split-Pool Synthesis of 1,3-Dioxanes Leading to Arrayed Stock Solutions of Single Compounds Sufficient for Multiple Phenotypic and Protein-Binding Assays”,J. Am. Chem. Soc.123:1740-1747, 2001.
Tallarico, et al., “An Alkylsily-Tethered, High-Capacity Solid Support Amenable to Diversity-Oriented Synthesis for One-Bead, One-Stock Solution Chemical Genetics”,J. Comb. Chem.3:312-318, 2001.
Taunton, et al., “Synthesis of Natural and Modified Trapoxins, Useful Reagents for Exploring Histone Deacetylase Function”,J. Am. Chem. Soc.118:10412-10422, 1996.
Uong, et al., “Stereocontrolled Functionlization of Acyclic Molybdenum-η3-Allyl Complexes: A New Approach to the Stereoselective Synthesis of 1,3-Diols”,J. Chem. Soc. Chem. Commun.,1285-1287, 1990.
Vong, et al., “Regio- and Stereocontrolled Functionalization of Acyclic Molybdenum -η3- Allyl Complexes”,J. Am. Chem. Soc.113:573-582, 1991
Wong, et al., “Structural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity”,J. Am. Chem. Soc.,125:5586-5587, 2003.
Grozinger Christina M.
Haggarty Stephen J.
Koeller Kathryn M.
Schreiber Stuart L.
Sternson Scott M.
Baker C. Hunter
Choate Hall & Stewart LLP
President and Fellows of Harvard College
Ward Paul V.
Wilson James O.
LandOfFree
Dioxanes and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dioxanes and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dioxanes and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730425